| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7fd73d64e57f7f255821ff0bba25465 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6445 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| filingDate |
1999-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27e1d5eff5af52fa8178922dd9447112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0031377a3d65384741e95321f1443d6d |
| publicationDate |
2000-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-19916242-A1 |
| titleOfInvention |
PSA-containing substance and its use |
| abstract |
A substance whose total concentration of prostate-specific antigen (PSA) with an N-terminal amino acid sequence of the sequence IVGGWECEKHSQVLVAS is at least 90% by weight has at least one isoform of PSA whose isoelectric point is at least 0.6 pI below the isoelectric point of non-glycated PSA is present in a proportion of at least 3.0% of the total PSA concentration. The substance can advantageously be used, for example, as a reference substance when determining the concentration of PSA in human blood or serum or when generating monoclonal isoform-specific PSA antibodies. |
| priorityDate |
1999-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |